By Role
Subscriptions
Continuing Education
Merial drug adds claims
Previcox controls pain and inflammation.
Merial announced that the company has received FDA approval to expand the label claim for Previcox, a canine osteoarthritis pain reliever. The expanded label claim includes the control of postoperative pain and inflammation associated with soft-tissue surgery in dogs. For more, visit previcox.com.
Related Videos
Related Content
